WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announced the expansion of its Fecal Dx® antigen testing platform ...
IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...